Our study demonstrates that c‐Maf‐driven LLPS activates the c‐Maf/RNA Pol II/Mtbp/c‐Myc axis, highlighting phase separation targeting as a promising therapeutic strategy for translocation‐associated MM patients. This evidence concerns the gene MAF and Miyoshi myopathy.